BMO Capital Initiates Coverage on Insmed Incorporated (INSM) with Outperform

Market Context

Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $107.02 with a market capitalization of $41.6B. The stock has gained 2.7% over the past 52 weeks.

Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Insmed Incorporated.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Insmed Incorporated

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 21, 2026	BMO Capital	Outperform	N/A
Jul 15, 2026	Wells Fargo	Overweight	N/A
Jul 10, 2026	Guggenheim	Buy	N/A
Jun 22, 2026	Evercore ISI Group	Outperform	N/A
Jun 08, 2026	JP Morgan	Overweight	N/A

Related Tools: Analyst Ratings Dashboard | View INSM Stock Page